bacteriophage Klebsiella | Apilak Grindeks tablets 10 mg, 25 pcs.

Special Price $14.72 Regular Price $25.00
In stock
SKU
BID471916
294.4 Reward Points will be used to purchase this product
Release form

Tablets.
Release form

Tablets.

Packing

25 pcs.

Pharmacological action

Apilak (royal jelly) is a secret produced by the allotrophic glands of working bees.

Vitamins, macro- and microelements, amino acids, including irreplaceable, a number of other biologically active substances are found in the composition of apilak.

Has a general tonic effect, stimulates cell metabolism.

Indications

convalescence period after illness

postpartum lactation disorder (hypogalactia)

as an aid in the treatment of neurotic disorders and arterial hypotension.

Contraindications

Hypersensitivity to the components of the drug and / or beekeeping products of Addison's disease.

Use during pregnancy and lactation

Possible after consulting a doctor.

Composition

1 tablet contains:

active ingredient:

bee royal jelly lyophilized - 10 mg

excipients:

lactose monohydrate,

talc,

calcium stearate, srdl potato krald, srd.

Dosing and Administration

Sublingual, keep the tablet under the tongue until completely resorbed.

Adults - 1 tablet (10 mg) 3 times a day for 10-15 days.

Side effects

Allergic reactions (stop taking the drug), sleep disorders (reduce the dose or cancel the drug).

Storage conditions

In a dry, dark place at a temperature of no higher than 25 РC.

active substance

Bacteriophage Klebsiella

Terms and conditions

without prescription

lekarstvennaja form

tablets

Indications

Climax, Osteoporosis9 d15fduct4 clavicle4254duct4 , Neuroses, Nedostatochnoe units, Gipotoniya

Grindeks, Latvia

Submit your review to Earn 10 Reward Points click here to login

Write Your Own Review
You're reviewing:bacteriophage Klebsiella | Apilak Grindeks tablets 10 mg, 25 pcs.

 Pharmacy Online Store | 9USD shipping cost only | Cheap price! Ship within 1-3 days! | USA, UK, EU shipping! | Fast shipping. 

Copyright © 2011-2024 Buy-Pharm, Inc. All rights reserved.